Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial evaluating fluphenazine in patients with refractory advanced multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [Phase 2]
A Phase 2 clinical trial update describes using arsenic trioxide to treat patients with recurrent or refractory acute leukemia, chronic myel…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization [Phase 2]
A Phase 2 clinical trial update evaluating an augmented stem cell mobilization strategy using Plerixafor (Mozobil) in patients at risk for p…
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants [Phase 2]
Phase 2 trial evaluating a conditioning regimen of bortezomib followed by high-dose melphalan and bortezomib for tandem stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating a combination of lenalidomide (Revlimid), melphalan, and dexamethasone as first-line therapy for multiple myeloma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Phase 1]
Phase 1 pharmacokinetics and safety study of azacitidine in cancer patients with and without impaired renal function has completed. Results …
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating temsirolimus for relapsed or refractory multiple myeloma has been completed.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial investigated the combination of tipifarnib and bortezomib in relapsed multiple myeloma, but the study has been te…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma [Phase 1]
This clinical trial update reports on a Phase 1 study evaluating the combination of lenalidomide and temsirolimus in patients with previousl…
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1]
Phase 1 clinical trial update reporting treated T cells followed by a stem cell transplant in patients with multiple myeloma. The study stat…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating Samarium-153 in combination with Bortezomib in patients with relapsed or refractory multiple myeloma; the …
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study evaluating Human Immune Globulin for AL amyloidosis-related heart dysfunction. Results w…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated a triplet regimen of bortezomib, liposomal doxorubicin, and thalidomide as first-line therapy for patients with…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation [Phase 1]
Phase 1 study of a partially HLA-matched irradiated allogeneic cellular therapy given after reduced-intensity total body irradiation; the tr…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease [Phase 1]
Phase 1 trial of irradiated donor lymphocytes with rituximab for relapsed or refractory lymphoproliferative disease; the study was terminate…
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? [NA]
A completed clinical trial evaluated whether treatment with bismuth could reduce toxicity from chemotherapy and radiotherapy in patients wit…
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings [NA]
A completed clinical trial update describing USCOM readings in patients with hematologic malignancies including leukemia, lymphoma, multiple…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function [Phase 2]
Phase 2 efficacy and safety study of bortezomib in patients with multiple myeloma and limited kidney function; the trial was terminated, wit…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: SCRI Tissue Testing Registry
This trial update indicates the SCRI Tissue Testing Registry study has been terminated; it involved patients with melanoma, myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure [Phase 3]
Phase 3 trial comparing dexamethasone-based chemotherapy with or without plasma exchange in newly diagnosed multiple myeloma with acute kidn…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Busulfan and Melphalan Conditioning in Multiple Myeloma [Phase 2]
This document provides a status update on a Phase 2 clinical trial evaluating busulfan and melphalan as conditioning therapy in patients wit…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma [Phase 3]
This Phase 3 trial in previously untreated elderly patients with multiple myeloma compared melphalan plus prednisolone with and without thal…
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer [Phase 1]
A Phase 1 trial evaluating donor umbilical cord blood transplant for patients with advanced hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies [NA]
This clinical trial update indicates that a pilot study of umbilical cord blood transplantation in adults with advanced hematopoietic malign…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This is a Phase II clinical trial evaluating clofarabine in patients with relapsed or refractory multiple myeloma. The study status is termi…